Editors:
- Includes supplementary material: sn.pub/extras
Part of the book series: Current Clinical Oncology (CCO)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (19 chapters)
-
Front Matter
-
Basic Mechanisms of Immune Evasion
-
Front Matter
-
-
Clinical Relevance of Immune Evasion
-
Front Matter
-
About this book
Reviews
"State of the art and insightful...illuminates the possibilities for developing effective immunotherapies that can block the mechanisms by which tumors evade the immune system in different histologic types of tumors." - Tumori
Editors and Affiliations
-
Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, USA
James H. Finke
-
Experimental Therapeutics Program, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, USA
Ronald M. Bukowski
Bibliographic Information
Book Title: Cancer Immunotherapy at the Crossroads
Book Subtitle: How Tumors Evade Immunity and What Can Be Done
Editors: James H. Finke, Ronald M. Bukowski
Series Title: Current Clinical Oncology
DOI: https://doi.org/10.1007/978-1-59259-743-7
Publisher: Humana Totowa, NJ
-
eBook Packages: Springer Book Archive
Copyright Information: Springer Science+Business Media New York 2004
Hardcover ISBN: 978-1-58829-183-7Published: 24 November 2003
Softcover ISBN: 978-1-4684-9844-8Published: 02 August 2012
eBook ISBN: 978-1-59259-743-7Published: 24 November 2003
Series ISSN: 2364-1134
Series E-ISSN: 2364-1142
Edition Number: 1
Number of Pages: XVII, 386
Topics: Oncology